Tumor Cell Content and RNA Integrity of Surgical Tissues from Different Types of Tumors and Its Correlation with Ex Vivo and In Vivo Ischemia

被引:0
|
作者
Xiao-Hui Zheng
Shao-Dan Zhang
Pei-Fen Zhang
Xi-Zhao Li
Ye-Zhu Hu
Tian Tian
Lin Zhu
Ruo-Zheng Wang
Wei-Hua Jia
机构
[1] Tumor Biobank,
[2] Sun Yat-sen University Cancer Center,undefined
[3] State Key Laboratory of Oncology in South China,undefined
[4] Collaborative Innovation Center for Cancer Medicine,undefined
[5] Affiliated Tumor Hospital of Xinjiang Medical University,undefined
来源
关键词
Tumor Cell Content; Excised Tumor Tissue; Cancer Research Advancement; Microchip Electrophoresis; Electronic Supplementary File;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:3764 / 3770
页数:6
相关论文
共 50 条
  • [31] Single-cell ex vivo drug response testing platform on fluid samples from patients with solid tumors
    Bankel, L.
    Wegmann, R.
    Dedes, K. J.
    Franzen, D.
    Bode, P. K.
    Zoche, M.
    Arnold, F.
    Moch, H.
    Manz, M. G.
    Britschgi, C.
    Snijder, B.
    ANNALS OF ONCOLOGY, 2021, 32 : S1222 - S1222
  • [32] Maintaining RNA Integrity for Transcriptomic Profiling of Ex Vivo Cultured Limbal Epithelial Stem Cells after Fluorescence-Activated Cell Sorting (FACS)
    Lei Liu
    Frederik Mølgaard Nielsen
    Simone Elkjær Riis
    Jeppe Emmersen
    Trine Fink
    Jesper Østergaard Hjortdal
    Chris Bath
    Vladimir Zachar
    Biological Procedures Online, 2017, 19
  • [33] Maintaining RNA Integrity for Transcriptomic Profiling of Ex Vivo Cultured Limbal Epithelial Stem Cells after Fluorescence-Activated Cell Sorting (FACS)
    Liu, Lei
    Nielsen, Frederik Molgaard
    Riis, Simone Elkjaer
    Emmersen, Jeppe
    Fink, Trine
    Hjortdal, Jesper Ostergaard
    Bath, Chris
    Zachar, Vladimir
    BIOLOGICAL PROCEDURES ONLINE, 2017, 19
  • [34] Ex vivo induction of polyclonal T cell responses against cutaneous T cell lymphoma by autologous dendritic cells transfected with amplified tumor RNA
    Ni, X.
    Richmond, H.
    Shiue, L.
    Shpall, E.
    Duvic, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 : S115 - S115
  • [35] Validation of an Ex Vivo Permeation Method for the Intestinal Permeability of Different BCS Drugs and Its Correlation with Caco-2 In Vitro Experiments
    Sanchez, Aroha B.
    Calpena, Ana C.
    Mallandrich, Mireia
    Clares, Beatriz
    PHARMACEUTICS, 2019, 11 (12)
  • [36] Ex Vivo Expansion and Drug Sensitivity Profiling of Circulating Tumor Cells from Patients with Small Cell Lung Cancer
    Lee, Hsin-Lun
    Chiou, Jeng-Fong
    Wang, Peng-Yuan
    Lu, Long-Sheng
    Shen, Chia-Ning
    Hsu, Han-Lin
    Burnouf, Thierry
    Ting, Lai-Lei
    Chou, Pai-Chien
    Chung, Chi-Li
    Lee, Kai-Ling
    Shiah, Her-Shyong
    Liu, Yen-Lin
    Chen, Yin-Ju
    CANCERS, 2020, 12 (11) : 1 - 17
  • [37] From cell lines to living biosensors: new opportunities to prioritize cancer dependencies using ex vivo tumor cultures
    Tseng, Yuen-Yi
    Boehm, Jesse S.
    CURRENT OPINION IN GENETICS & DEVELOPMENT, 2019, 54 : 33 - 40
  • [38] T cell receptor repertoires of ex vivo–expanded tumor-infiltrating lymphocytes from breast cancer patients
    In Ah Park
    Hajar Rajaei
    Young-Ae Kim
    Hyeonjin Lee
    Heejae Lee
    Jeong-Han Seo
    Sun-Hee Heo
    In Hye Song
    Gyungyub Gong
    Hee Jin Lee
    Immunologic Research, 2020, 68 : 233 - 245
  • [39] Mechanistic divergence of immune checkpoint inhibition by an ex vivo platform derived from patient tumors where tumor and immune microenvironment is preserved
    Biswas, M.
    Brijwani, N.
    Balakrishnan, B.
    Muthusamy, O.
    Thiyagarajan, S.
    Mehrotra, D. G.
    Majumder, B.
    Radhakrishnan, P.
    Majumder, P. K.
    ANNALS OF ONCOLOGY, 2017, 28
  • [40] Tumor infiltrating lymphocyte (TIL) harvest and ex vivo expansion from primary and metastatic (met) uveal melanoma (UM) tumors.
    Patel, Sapna Pradyuman
    Forget, Marie-Andree
    Kreidieh, Firas Y.
    Pelster, Meredith
    Davies, Michael A.
    Amaria, Rodabe Navroze
    Gombos, Dan S.
    Bernatchez, Chantale
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)